Cargando…
An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer
Breast cancer (BC) is the second most common cause of cancer-related deaths and the most frequently diagnosed cancer in females. Among breast cancer types, HER2-positive breast cancer occurs in nearly 20% of human breast cancers and is associated with increased aggressiveness, poor prognosis, and sh...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255238/ https://www.ncbi.nlm.nih.gov/pubmed/35800378 http://dx.doi.org/10.20517/cdr.2022.09 |